CD-SINS Assay for Protein Colloidal Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for assessing protein colloidal interactions are inadequate for rapidly determining the dynamic range of a protein's self-association under varying conditions, leading to instability at high concentrations and aggregation issues during formulation and storage.

Innovation Solution

Concentration-dependent self-interaction nanoparticle spectroscopy (CD-SINS) measures the propensity of proteins to self-assemble across a range of concentrations, ionic strengths, and pH conditions, using gold nanoparticles to assess absorbance intensity ratios and predict stability at high concentrations.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If protein concentration is increased to achieve therapeutically effective doses, then the dose strength is improved, but colloidal interactions increase causing aggregation and instability

Engineering Contradiction:
Improveprotein concentrationVSAvoidprotein stability
Core Design Contradiction:
Quantity of substanceVSStability of the object's composition

Solution Approach 1:

The patent applies preliminary action by measuring the second virial coefficient (B22) early in the discovery and development process to predict colloidal stability. This allows selection of protein variants with favorable self-interaction properties before committing to large-scale production and formulation, preventing aggregation issues from manifesting later in development.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent employs parameter changes by systematically varying protein sequence, pH, ionic strength, and temperature to measure how these parameters affect B22 values. This enables identification of optimal formulation conditions that maintain protein stability at high concentrations by adjusting these physical-chemical parameters.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If current virial coefficient measurement methods are used, then measurement accuracy is maintained, but assessment speed and throughput are insufficient for rapid screening

Engineering Contradiction:
Improvevirial coefficient measurement accuracyVSAvoidassessment throughput
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent applies segmentation by dividing the comprehensive stability assessment into multiple independent measurements at different concentrations, pH values, and temperatures. Each measurement contributes to the overall B22 characterization, allowing parallel processing and accelerated data collection while maintaining measurement accuracy through systematic analysis of segmented experimental data.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent replaces traditional mechanical/physical measurement methods (such as analytical ultracentrifugation or light scattering) with surface plasmon resonance (SPR) technology. SPR provides rapid, real-time measurement of protein self-interactions with high throughput capability, substituting slower conventional techniques while maintaining or improving measurement precision.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

CD-SINS enables the selection of proteins for high-concentration formulations with improved stability and reduced aggregation, facilitating the development of biopharmaceuticals with suitable rheology and viscosity for effective administration.

Implementation Method 1

measures the light transmitted through the sample; and calculating the first absorbance intensity ratio of the sample

Methodology Applied
Scientific EffectAbsorbance spectroscopy: Absorption Spectroscopy

Data Source

PatentUS20240280582A1Concentration-dependent self-interaction assay
Publication Date: 2024.08.22 REGENERON PHARMACEUTICALS INC
  • US20240280582A1 patent drawing
  • US20240280582A1 patent drawing
  • US20240280582A1 patent drawing

AI summary

Methods for producing high concentration protein formulations having high stability are provided. Assays for selecting proteins and formulation conditions that have high self-repulsive attributes are used as an early step in the manufacturing process. Specifically, a protein concentration-dependent self-interaction nanoparticle spectroscopy method is employed as a protein colloidal interaction assay.